Data Supplement
Files in this Data Supplement:
- Supplemental Figures S1-S6 -
Figure S1. The in vitro LC50 concentrations of curcumin for cancers of the reproductive system, plotted as a function of cell line and incubation time.
Figure S2. The in vitro LC50 concentrations of curcumin for cancers of the digestive system, plotted as a function of cell line and incubation time.
Figure S3. The in vitro LC50 concentrations of curcumin for cancers of the lymphatic and immune system, plotted as a function of cell line and incubation time.
Figure S4. The in vitro LC50 concentrations of curcumin for cancers of the nervous system, plotted as a function of cell line and incubation time.
Figure S5. The in vitro LC50 concentrations of curcumin for cancers of the respiratory system, urinary system, skin, and skeletal system plotted as a function of cell line and incubation time.
Figure S6. Scatterplot of IC50 values of curcumin plotted as a function of incubation time.
- Supplemental Table S3.6 -
Supplemental Table S3.6 Nervous System
- Supplemental Table S3.7 -
Supplemental Table S3.7 Skin
- Supplemental Table S3.8 -
Supplemental Table S3.8 Skeletal System
- Supplemental Table S3.9 -
Supplemental Table S3.9 Urinary System
- Supplemental Table S3.10 -
Supplemental Table S3.10 Connective Tissue and Fluids
- Supplemental Table S1 -
S1: Summary of curcumin-target molecule interactions on the basis of molecular docking and/or site-directed mutagenesis studies.
- Supplemental Table S2 -
Table S2
- Supplemental Table S3.0 -
Supplemental Table S3.0 references
- Supplemental Table S3.1 -
Supplemental Table S3.1 Reproductive System
- Supplemental Table S3.2 -
Supplemental Table S3.2 Lymphatic and Immune System
- Supplemental Table S3.3 -
Supplemental Table S3.3 Digestive System
- Supplemental Table S3.4 -
Supplemental Table S3.4 Respiratory System
- Supplemental Table S3.5 -
Supplemental Table S3.5 Endocrine System